Clinical trial
Risk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic…
NCT00482352 · Children's Oncology Group, Other · Completed
Key facts
| NCT number | NCT00482352 |
|---|---|
| Title | Risk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia |
| Official title | Classification Of Acute Lymphoblastic Leukemia |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia |
| Intervention type | Other |
| Interventions | laboratory biomarker analysis |
| Enrollment | 11,196 |
| Start date | Dec 1, 2003 |
| Primary completion | Apr 1, 2012 |
| Completion | Jun 30, 2023 |
| First posted | Jun 5, 2007 |
| Last update posted | Aug 3, 2023 |
| Countries | Australia, Canada, New Zealand, Puerto Rico, Switzerland, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: